Ameriprise’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.4M | Buy |
800,519
+14,436
| +2% | +$284K | ﹤0.01% | 1592 |
|
|
2025
Q4 | $14.9M | Sell |
786,083
-41,468
| -5% | -$769K | ﹤0.01% | 1627 |
|
|
2025
Q3 | $15.4M | Sell |
827,551
-50,359
| -6% | -$941K | ﹤0.01% | 1586 |
|
|
2025
Q2 | $16.2M | Buy |
877,910
+12,184
| +1% | +$216K | ﹤0.01% | 1485 |
|
|
2025
Q1 | $15.1M | Sell |
865,726
-46,484
| -5% | -$784K | ﹤0.01% | 1493 |
|
|
2024
Q4 | $15.8M | Buy |
912,210
+58,919
| +7% | +$1.08M | ﹤0.01% | 1491 |
|
|
2024
Q3 | $15.9M | Buy |
853,291
+482,818
| +130% | +$8.14M | ﹤0.01% | 1461 |
|
|
2024
Q2 | $5.71M | Buy |
370,473
+500
| +0.1% | +$7.14K | ﹤0.01% | 2212 |
|
|
2024
Q1 | $5.46M | Buy |
369,973
+84,663
| +30% | +$1.17M | ﹤0.01% | 2305 |
|
|
2023
Q4 | $4.07M | Sell |
285,310
-581,537
| -67% | -$8.26M | ﹤0.01% | 2503 |
|
|
2023
Q3 | $12.1M | Buy |
866,847
+125,095
| +17% | +$1.6M | ﹤0.01% | 1546 |
|
|
2023
Q2 | $8.73M | Buy |
741,752
+264,141
| +55% | +$3.01M | ﹤0.01% | 1889 |
|
|
2023
Q1 | $5.49M | Sell |
477,611
-949,109
| -67% | -$11.7M | ﹤0.01% | 2255 |
|
|
2022
Q4 | $17.7M | Sell |
1,426,720
-891,172
| -38% | -$11.4M | 0.01% | 1297 |
|
|
2022
Q3 | $30.6M | Buy |
2,317,892
+48,856
| +2% | +$722K | 0.01% | 921 |
|
|
2022
Q2 | $31.5M | Buy |
2,269,036
+1,676,098
| +283% | +$22.4M | 0.01% | 934 |
|
|
2022
Q1 | $8.69M | Sell |
592,938
-508,889
| -46% | -$6.96M | ﹤0.01% | 2031 |
|
|
2021
Q4 | $14.8M | Buy |
1,101,827
+463,050
| +72% | +$6.55M | ﹤0.01% | 1644 |
|
|
2021
Q3 | $9.4M | Sell |
638,777
-133,858
| -17% | -$2.26M | ﹤0.01% | 1903 |
|
|
2021
Q2 | $14.1M | Sell |
772,635
-740,241
| -49% | -$13.2M | ﹤0.01% | 1641 |
|
|
2021
Q1 | $26.3M | Buy |
1,512,876
+12,111
| +0.8% | +$213K | 0.01% | 1119 |
|
|
2020
Q4 | $26.1M | Buy |
1,500,765
+308,063
| +26% | +$4.92M | 0.01% | 1060 |
|
|
2020
Q3 | $16.4M | Sell |
1,192,702
-83,203
| -7% | -$1.22M | 0.01% | 1207 |
|
|
2020
Q2 | $18.3M | Buy |
1,275,905
+14,918
| +1% | +$196K | 0.01% | 1107 |
|
|
2020
Q1 | $13.8M | Buy |
1,260,987
+291,026
| +30% | +$5.37M | 0.01% | 1169 |
|
|
2019
Q4 | $20.7M | Buy |
969,961
+423,119
| +77% | +$9.47M | 0.01% | 1173 |
|
|
2019
Q3 | $12.6M | Sell |
546,842
-274,610
| -33% | -$5.86M | 0.01% | 1520 |
|
|
2019
Q2 | $16.2M | Buy |
821,452
+30,385
| +4% | +$592K | 0.01% | 1328 |
|
|
2019
Q1 | $15.4M | Buy |
791,067
+89,139
| +13% | +$1.69M | 0.01% | 1331 |
|
|
2018
Q4 | $11.6M | Sell |
701,928
-22,695
| -3% | -$457K | 0.01% | 1479 |
|
|
2018
Q3 | $16.8M | Sell |
724,623
-14,377
| -2% | -$326K | 0.01% | 1446 |
|
|
2018
Q2 | $16.1M | Sell |
739,000
-14,068
| -2% | -$275K | 0.01% | 1345 |
|
|
2018
Q1 | $13.3M | Sell |
753,068
-358,525
| -32% | -$6.32M | 0.01% | 1430 |
|
|
2017
Q4 | $20.9M | Sell |
1,111,593
-215,008
| -16% | -$4.28M | 0.01% | 1035 |
|
|
2017
Q3 | $29.1M | Buy |
1,326,601
+709,983
| +115% | +$16M | 0.01% | 823 |
|
|
2017
Q2 | $14.9M | Buy |
616,618
+181,599
| +42% | +$4.62M | 0.01% | 1246 |
|
|
2017
Q1 | $12.1M | Buy |
435,019
+81,319
| +23% | +$2.13M | 0.01% | 1379 |
|
|
2016
Q4 | $8.64M | Buy |
353,700
+11,008
| +3% | +$252K | ﹤0.01% | 1639 |
|
|
2016
Q3 | $8.56M | Buy |
342,692
+26,776
| +8% | +$641K | ﹤0.01% | 1584 |
|
|
2016
Q2 | $6.52M | Buy |
315,916
+12,662
| +4% | +$264K | ﹤0.01% | 1740 |
|
|
2016
Q1 | $6.09M | Sell |
303,254
-236
| -0.1% | -$4.52K | ﹤0.01% | 1806 |
|
|
2015
Q4 | $6.14M | Sell |
303,490
-1,313
| -0.4% | -$27.7K | ﹤0.01% | 1834 |
|
|
2015
Q3 | $7.07M | Sell |
304,803
-3,158
| -1% | -$80.6K | ﹤0.01% | 1736 |
|
|
2015
Q2 | $7.93M | Sell |
307,961
-61,966
| -17% | -$1.76M | ﹤0.01% | 1787 |
|
|
2015
Q1 | $12.3M | Buy |
369,927
+36,261
| +11% | +$1.18M | 0.01% | 1395 |
|
|
2014
Q4 | $10.1M | Buy |
333,666
+33,586
| +11% | +$926K | 0.01% | 1489 |
|
|
2014
Q3 | $7.3M | Sell |
300,080
-311,428
| -51% | -$8.64M | ﹤0.01% | 1734 |
|
|
2014
Q2 | $17.6M | Buy |
611,508
+14,350
| +2% | +$417K | 0.01% | 1112 |
|
|
2014
Q1 | $16.7M | Buy |
597,158
+100,225
| +20% | +$2.75M | 0.01% | 1131 |
|
|
2013
Q4 | $13M | Sell |
496,933
-29,875
| -6% | -$770K | 0.01% | 1302 |
|
|
2013
Q3 | $12.1M | Buy |
526,808
+1,024
| +0.2% | +$25.2K | 0.01% | 1341 |
|
|
2013
Q2 | $13.7M | Buy |
+525,784
| New | +$15.2M | 0.01% | 1230 |
|
Other funds holding SBRA
VPM
VCM
N
Ameriprise's SBRA Position: Q1 2026 in Review
Ameriprise increased its Sabra Healthcare REIT (SBRA) stake by 1.8% in Q1 2026, buying an estimated $284K and bringing the position to 800,519 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.
Ameriprise first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.5M in Q2 2022. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Ameriprise held 800,519 shares of Sabra Healthcare REIT worth $15.4M as of Q1 2026.
- Ameriprise bought 14,436 Sabra Healthcare REIT shares in Q1 2026, an estimated $284K.
- Sabra Healthcare REIT made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1592 holding.
- Ameriprise first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Sabra Healthcare REIT position peaked at $31.5M in Q2 2022.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.